王岚 副主任医师，讲师
硕士招生类型：学术型；专业型
硕士招生专业：内科学（呼吸内科学）
博士招生类型：无
博士招生专业：无
所在院系：附属肺科医院
联系方式：lanwang@tongji.edu.cn
课题组链接：
研究方向
主要任职
科研业绩

肺血管疾病的临床和基础研究 Clinical and Basic Research on Pulmonary Vascular Diseases
上海市肺科医院循环科副主任（主持工作）；
上海市医学会呼吸病学专科分会第十一届委员会委员；
上海市医学会呼吸病学会肺血管病学组副组长；
中国罕见病联盟呼吸病学分会第一届委员；
中华医学会呼吸病学分会第十一届委员会肺血管病专业组成员
Vice director of the pulmonary circulation laboratory of Shanghai Pulmonary Hospital affiliated to Tongji University ；
Member of the Shanghai Medical Association Respiratory Disease；
Vice leader of the Department of Pulmonary Vascular Diseases of the Shanghai Medical Association Respiratory Disease. ；
Member of the Chinese Association of Rare Diseases Respiratory Medicine Branch；
Member of the Department of Pulmonary Vascular Diseases of the Chinese Medical Association Respiratory Disease
主持主要科研项目：
1、中性粒细胞分泌的ISG15调控肺动脉平滑肌细胞中PLCγ1-CaMK II信号通路在肺血管重构中的作用及机制研究，国家青年科学基金项目，**，2021-01-01至2023-12-31 , 24万；
2、改良肺动脉球囊扩张术联合利奥西呱治疗不可手术的慢性血栓栓塞性肺动脉高压患者的疗效及安全性：一项单中心、开放标签、前瞻性、优效性、随机平行对照临床研究 (PRACTICE研究)，2020年院级临床研究项目，2021.1.1-2023.12.30；
3、CaMKII/RyR2信号轴在缺氧性肺动脉高压发病机制中的作用研究，上海市肺科医院国家自然科学基金培育项目，项目承担人，项目编号：fk1916，2019.11.1-2020.10.1。
发表文章：
1.Rui Zhang, Lan Wang, Qin-Hua Zhao, Rong Jiang, Su-Gang Gong, Xin Jiang, Xi-Qi Xu, Yang-Yang He, Yuan Li, Zhi-Cheng Jing. Alteration of extracellular superoxide dismutase in idiopathic pulmonary arterial hypertension. Frontiers in Medcine；
2.Yi-Lan Yang, Yan-Zhe Yu, Ping Yuan, Su-Gang Gong, Chuan-Yu Wang, Yuan Li, Qin-Hua Zhao, Rong Jiang, Wen-Hui Wu, Jing He, Jian Guo, Ci-Jun Luo, Hong-Ling Qiu, Jin-Ling Li, Lan Wang, Wei-Ping Xie, Jin-Ming Liu .Sex differences of hemodynamics during acute vasoreactivity testing to predict the outcomes of chronic thromboembolic pulmonary hypertension. Clin Respir J.2020 Feb 24；
3.Xiu-jun Zhong, Jie Tang, Qin-Hua Zhao, Su-Gang Gong, Rong Jiang, Jin-Ming Liu, Lan Wang, Can the diastolic pulmonary pressure gradient provide cardiopulmonary capacity information in patients with pulmonary hypertension and left heart disease? Int J Cardiol. 2020 Apr 15;305:138；
4.Jiang R, Zhao QH, Wu WH, Zhang R, Yuan P, Gong SG, He J, Luo CJ, Qiu HL, Wang L, Liu JM. Efficacy and Safety of a Calcium Sensitizer, Levosimendan, in Patients with Right Heart Failure due to Pulmonary Hypertension. Clin Respir J. 2017 Sep 1；
5.Wang L, Jin YZ, Zhao QH, Jiang R, Wu WH, Gong SG, He J, Liu JM, Jing ZC. Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension. Int J Chron Obstruct Pulmon Dis. 2017 Nov 22;12:3353-3360；
6.Lan Wang, Qin-Hua Zhao, et al. Clinical and Hemodynamic Characteristics of Pulmonary Hypertension associated with Interstitial Lung Disease in China. The Clinical Respiratory Journal. Clin Respir J. 2016 Dec 27. doi: 10.1111/crj.12604；
7.Lan Wang, Sen Jiang, Jing-Yun Shi, Su-Gang Gong, Qin-Hua Zhao, Rong Jiang, Ping Yuan, Bigyan Pudasaini, Jing He, Jin-Ming Liu. Pulmonary Hypertension in Bronchiectasis: Hemodynamic Characteristics and Effect of Pulmonary Arterial Hypertension Therapies. Frontier of Medicine. 2016 Sep;10(3):336-44；
8.Jiang R, Wang L, Zhu CT, Yuan P, Pudasaini B, Zhao QH, Gong SG, He J, Liu JM, Hu QH. Comparative effectiveness of sildenafil for pulmonary hypertension due to left heart disease with HFrEF. Hypertensions Res. 2015 Dec;38(12):829-39.